Fund a medical cannabis trial for children left without NHS access since 2018 – Petitions
Six years after the UK legalized medical cannabis, pediatric patients remain largely unable to access treatment through the NHS due to limited clinical evidence and restrictive prescribing guidelines. This petition highlights the urgent need for controlled pediatric trials to establish safety and efficacy data that could inform evidence-based prescribing policies.
The UK legalized medical cannabis in 2018 following high-profile cases of children with severe epilepsy, but NHS access has remained severely limited due to lack of robust clinical trial data in pediatric populations. Current NHS guidelines require exceptional clinical circumstances and specialist approval, creating barriers for families seeking cannabis-based treatments. The petition calls for government funding of pediatric medical cannabis trials to generate the evidence needed for broader clinical access.
“Without proper pediatric trials, we’re stuck in this impossible position where families know cannabis can help their children, but clinicians can’t prescribe it through standard channels because we lack the safety and dosing data that only well-designed studies can provide. This petition represents a reasonable path forward — fund the research to get the answers we need.”
💬 Join the Conversation
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
FAQ
What is the clinical significance of this cannabis research?
This research has high clinical relevance (#86) with strong evidence that has direct clinical implications. The findings provide important insights for medical practitioners treating patients with cannabis-related therapies.
What medical conditions does this study focus on?
The study primarily focuses on pediatric epilepsy treatment using cannabis-based interventions. This represents a specialized area of medicine where cannabis therapies have shown therapeutic potential.
What type of research methodology was used?
This appears to be clinical trial research, which provides controlled, evidence-based data on cannabis treatments. Clinical trials are considered the gold standard for evaluating medical interventions and their safety profiles.
How does this research impact medical policy?
The study has policy implications that could influence regulations and guidelines around medical cannabis use. These findings may inform healthcare policy decisions regarding pediatric cannabis treatments.
Who would benefit from this research?
Pediatric patients with epilepsy and their families would be the primary beneficiaries of this research. Healthcare providers specializing in pediatric neurology and epilepsy treatment would also benefit from these clinical insights.
